1,008 top medical experts on Iron-Deficiency Anemia across 88 countries and 37 U.S. states, including 901 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Iron-Deficiency Anemia: Anemia characterized by decreased or absent iron stores, low serum iron concentration, low transferrin saturation, and low hemoglobin concentration or hematocrit value. The erythrocytes are hypochromic and microcytic and the iron binding capacity is increased.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Iron Deficiencies (1,526), Hypochromic Anemia (627).
  4. Clinical Trials ClinicalTrials.gov : at least 576 including 17 Active, 348 Completed, 69 Recruiting


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. Suchdev, Parminder S   Pediatrics   ClinicalTrials.gov Google Publications
    Department of Pediatrics, Emory University, and Emory Global Health Institute, Atlanta, GA, USA; Nutrition Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: . Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Disclosed payments from biomedical company (RADIOMETER AMERICA, INC) in 2021 for $104
    Subjects: Anemia, Iron-Deficiency; Iron; Inflammation; Biomarkers; Micronutrients; Nutritional Status
    Categories: Epidemiology; Blood; Diagnosis; Administration & Dosage; Complications; Therapeutic Use
    Overview of the Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) Project. (2016)
    Assessment of iron status in settings of inflammation: challenges and potential approaches. (2017)

  2. Goodnough, Lawrence Tim   Internal Medicine   Google Publications
    Stanford University School of Medicine, Stanford, CA. Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial  Review 
    Disclosed payments in 2021 from 3 biomedical companies, totalling $125,724.71, including $125,609 from  Stryker Corporation
    Subjects: Anemia, Iron-Deficiency; Ferric Compounds; Iron; Maltose; Erythropoiesis; Antimicrobial Cationic Peptides
    Categories: Administration & Dosage; Drug Therapy; Analogs & Derivatives; Blood; Physiopathology; Therapeutic Use
    Detection, evaluation, and management of iron-restricted erythropoiesis. (2010)
    A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia. (2014)

  3. Georgieff, Michael K   Neonatal-Perinatal Medicine   Google Publications
    Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA. Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Subjects: Anemia, Iron-Deficiency; Hippocampus; Iron; Brain; Iron Deficiencies; Malaria
    Categories: Metabolism; Blood; Drug Therapy; Genetics; Therapeutic Use; Administration & Dosage
    Long-term brain and behavioral consequences of early iron deficiency. (2011)
    Iron assessment to protect the developing brain. (2017)

  4. Ganz, Tomas   Pulmonary Disease   Google Publications
    David Geffen School of Medicine, UCLA, Los Angeles, CA.
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Disclosed payments in 2021 from 6 biomedical companies, totalling $11,508, including $4,225 from  Pharmacosmos Therapeutics Inc.
    Subjects: Anemia, Iron-Deficiency; Antimicrobial Cationic Peptides; Hepcidins; Iron; Neoplasms; Polycythemia Vera
    Categories: Metabolism; Blood; Administration & Dosage; Complications; Etiology; Pathology
    Detection, evaluation, and management of iron-restricted erythropoiesis. (2010)
    Iron Balance and the Role of Hepcidin in Chronic Kidney Disease. (2016)

  5. Pergola, Pablo E   Nephrology   Google Publications
    Renal Associates PA, San Antonio, Texas, USA.
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Medical school: Other (MD, 1988)
    Medicare Accepted
    Disclosed payments in 2021 from 23 biomedical companies, totalling $5,025.97, including $2,381.67 from  AstraZeneca Pharmaceuticals LP
    Subjects: Anemia, Iron-Deficiency; Ferric Compounds; Renal Insufficiency, Chronic; Hematinics; Hemoglobins; Fibroblast Growth Factors
    Categories: Complications; Drug Therapy; Therapeutic Use; Administration & Dosage; Blood; Epidemiology
    Iron Deficiency in Chronic Kidney Disease: Updates on Pathophysiology, Diagnosis, and Treatment. (2020)
    A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5. (2015)

  6. Coyne, Daniel W   Nephrology   Google Publications
    Washington University, St. Louis, MO. Electronic address: .
    Physician  Highly Published  Clinical Trial 
    Medical school: Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University (MD, 1983)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 84/100
    Disclosed payments in 2021 from 10 biomedical companies, totalling $14,021, including $4,876 from  AstraZeneca Pharmaceuticals LP
    Subjects: Anemia, Iron-Deficiency; Hematinics; Kidney Failure, Chronic; Iron; Renal Dialysis; Disaccharides
    Categories: Therapeutic Use; Drug Therapy; Administration & Dosage; Complications; Blood; Diagnosis
    A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia. (2016)
    A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients. (2015)

  7. Babitt, Jodie L   Internal Medicine   Google Publications
    Division of Nephrology, Program in Membrane Biology, Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114 . Top Hospital
    Physician 
    Medical school: Harvard Medical School (MD, 1999)
    Medicare Accepted
    Disclosed payments from biomedical company (Alnylam Pharmaceuticals Inc.) in 2021 for $270
    Subjects: Anemia, Iron-Deficiency; Iron; Adenine; Bone Morphogenetic Protein 6; Disease Models, Animal; Erythrocytes
    Categories: Metabolism; Pharmacology; Complications; Drug Effects; Drug Therapy; Physiology
    Regulation of TMPRSS6 by BMP6 and iron in human cells and mice. (2011)
    The iron cycle in chronic kidney disease (CKD): from genetics and experimental models to CKD patients. (2014)

  8. Rockey, Don C   Hepatology   Google Publications
    Department of Medicine, Medical University of South Carolina, Charleston, SC.
    Physician  Guideline 
    Medical school: Other (MD, 1984)
    Medicare Accepted
    Disclosed payments in 2021 from 2 biomedical companies, totalling $7,500, including $6,000 from  Novo Nordisk Inc
    Subjects: Anemia, Iron-Deficiency; Evidence-Based Medicine; Gastrointestinal Diseases; Iron; Endoscopy, Gastrointestinal; Gastroenterology
    Categories: Diagnosis; Standards; Blood
    AGA Technical Review on Gastrointestinal Evaluation of Iron Deficiency Anemia. (2020)
    Spotlight: Gastrointestinal Evaluation of Iron Deficiency Anemia. (2020)

  9. Chertow, Glenn M   Nephrology   Google Publications
    Stanford University, Palo Alto, California. Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 65/100
    Disclosed payments in 2021 from 34 biomedical companies, totalling $379,970.59, including $289,961.26 from  Outset Medical Inc
    Subjects: Anemia, Iron-Deficiency; Ferric Compounds; Renal Insufficiency, Chronic; Kidney Failure, Chronic; Iron; Administration, Intravenous
    Categories: Drug Therapy; Therapeutic Use; Complications; Blood; Administration & Dosage; Adverse Effects
    Randomized trial of intravenous iron-induced hypophosphatemia. (2018)
    A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5. (2015)

  10. Shander, Aryeh   Anesthesiology   Google Publications
    Department of Anesthesiology and Critical Care Medicine, Englewood Health, TeamHealth, Englewood, New Jersey.
    Physician  Highly Published 
    Disclosed payments in 2021 from 54 biomedical companies, totalling $157,415.3, including $97,728.07 from  Stryker Corporation
    Subjects: Anemia, Iron-Deficiency; Iron; Iron Deficiencies; Heart Diseases; Administration, Intravenous; Anaphylaxis
    Categories: Drug Therapy; Administration & Dosage; Complications; Therapeutic Use; Adverse Effects; Chemically Induced
    Management of Perioperative Iron Deficiency Anemia. (2019)
    Current misconceptions in diagnosis and management of iron deficiency. (2017)

  11. Duggan, Christopher P   Pediatric Gastroenterology  Google Publications
    Division of Gastroenterology, Hepatology and Nutrition, Boston Childrens Hospital, Boston, MA, USA.
    Physician  Highly Published  Clinical Trial 
    Medical school: Johns Hopkins University School of Medicine (MD, 1987)
    Medicare Accepted
    Subjects: Anemia, Iron-Deficiency; HIV Infections; Iron; Dietary Supplements; Iron, Dietary; Intestinal Diseases
    Categories: Epidemiology; Blood; Administration & Dosage; Complications; Etiology; Adverse Effects
    High prevalence of multiple micronutrient deficiencies in children with intestinal failure: a longitudinal study. (2011)
    Iron deficiency and anemia predict mortality in patients with tuberculosis. (2012)

  12. Buchanan, George R   Pediatric Hematology-Oncology   Google Publications
    Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX. Top Hospital
    Physician  Highly Published  Clinical Trial 
    Subjects: Anemia, Iron-Deficiency; Iron; Ferric Compounds; Hematinics; Anemia; Child Nutrition Disorders
    Categories: Administration & Dosage; Drug Therapy; Metabolism; Pharmacology; Therapy; Diagnosis
    Effect of Low-Dose Ferrous Sulfate vs Iron Polysaccharide Complex on Hemoglobin Concentration in Young Children With Nutritional Iron-Deficiency Anemia: A Randomized Clinical Trial. (2017)
    Intravenous Ferric Carboxymaltose in Children with Iron Deficiency Anemia Who Respond Poorly to Oral Iron. (2017)

  13. Brittenham, Gary M   Pediatric Hematology-Oncology   ClinicalTrials.gov Google Publications
    Department of Pediatrics, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
    Physician 
    Subjects: Anemia, Iron-Deficiency; Hemoglobins; Iron, Dietary; Protoporphyrins; Algorithms; Biomarkers
    Categories: Blood; Epidemiology; Diagnosis; Methods; Administration & Dosage; Chemistry
    Physiologically based serum ferritin thresholds for iron deficiency in children and non-pregnant women: a US National Health and Nutrition Examination Surveys (NHANES) serial cross-sectional study. (2021)
    Accuracy of Capillary Hemoglobin Measurements for the Detection of Anemia among U.S. Low-Income Toddlers and Pregnant Women. (2017)

  14. Lewis, Gregory D   Cardiovascular Disease   ClinicalTrials.gov Google Publications
    Division of Cardiology, Massachusetts General Hospital, Boston G.D.L.. Top Hospital
    Physician  Clinical Trial 
    Medical school: University of Rochester School of Medicine and Dentistry (MD, 1999)
    Medicare Accepted
    Disclosed payments in 2021 from 4 biomedical companies, totalling $17,760, including $7,560 from  American Regent
    Subjects: Anemia, Iron-Deficiency; Heart Failure; Hematinics; Ferric Compounds; Iron Compounds; Heart Failure, Systolic
    Categories: Drug Therapy; Administration & Dosage; Therapeutic Use; Analogs & Derivatives; Blood; Drug Effects
    Randomized Placebo-Controlled Trial of Ferric Carboxymaltose in Heart Failure With Iron Deficiency: Rationale and Design. (2021)
    Oral Iron Therapy for Heart Failure With Reduced Ejection Fraction: Design and Rationale for Oral Iron Repletion Effects on Oxygen Uptake in Heart Failure. (2016)

  15. Agarwal, Rajiv   Nephrology   ClinicalTrials.gov Google Publications
    Department of Medicine, Indiana University School of Medicine and Richard L. Roudebush Veterans Administration Medical Center, Indianapolis, Indiana, USA.
    Physician  Clinical Trial 
    Disclosed payments in 2021 from 54 biomedical companies, totalling $105,037.04, including $80,747.33 from  Bayer HealthCare Pharmaceuticals Inc.
    Subjects: Anemia, Iron-Deficiency; Renal Insufficiency, Chronic; Ferric Compounds; Ferrous Compounds; Glucaric Acid; Hematinics
    Categories: Administration & Dosage; Complications; Drug Therapy; Etiology; Adverse Effects; Chemically Induced
    A randomized trial of intravenous and oral iron in chronic kidney disease. (2015)
    Proteinuria induced by parenteral iron in chronic kidney disease--a comparative randomized controlled trial. (2011)

  16. Greer, Frank R   Neonatal-Perinatal Medicine   Google Publications
    1 University of Wisconsin, Madison, WI, USA.
    Physician 
    Subjects: Anemia, Iron-Deficiency; Breast Feeding; Child Health Services; Diet; Electronic Health Records; Health Education
    Categories: Statistics & Numerical Data; Diagnosis; Metabolism; Standards; Chemistry; Epidemiology
    Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age). (2010)
    Improving Rates of Screening for Anemia in Infancy. (2018)

  17. Mast, Alan E   Clinical Pathology/Laboratory Medicine   ClinicalTrials.gov Google Publications
    Blood Research Institute, Versiti, Milwaukee, Wisconsin, USA.
    Physician  Clinical Trial 
    Disclosed payments from biomedical company (Novo Nordisk Health Care AG) in 2021 for $3,780
    Subjects: Anemia, Iron-Deficiency; Blood Donors; Ferritins; Iron; Biomarkers; Delivery of Health Care
    Categories: Etiology; Blood; Statistics & Numerical Data; Administration & Dosage; Adverse Effects; Analysis
    A randomized, blinded, placebo-controlled trial of education and iron supplementation for mitigation of iron deficiency in regular blood donors. (2016)
    Restless legs syndrome, pica, and iron status in blood donors. (2013)

  18. Cantor, Amy G   Family Medicine  Google Publications
    Department of Medical Informatics & Clinical Epidemiology, Pacific Northwest Evidence-based Practice Center, Oregon Health & Science University, Portland, Oregon. Top Hospital
    Physician  Review 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 80.3/100
    Subjects: Anemia, Iron-Deficiency; Iron; Mass Screening; Pregnancy Complications, Hematologic; Dietary Supplements
    Categories: Prevention & Control; Administration & Dosage; Diagnosis; Drug Therapy
    Routine iron supplementation and screening for iron deficiency anemia in pregnancy: a systematic review for the U.S. Preventive Services Task Force. (2015)
    Screening and routine supplementation for iron deficiency anemia: a systematic review. (2015)

  19. Achebe, Maureen M   Hematology & Oncology  Google Publications
    Harvard Medical School, Boston, Massachusetts. Top Hospital
    Physician  Clinical Trial 
    Medical school: Other (MD, 1995)
    Medicare Accepted
    Disclosed payments in 2021 from 3 biomedical companies, totalling $4,706, including $2,695 from  Global Blood Therapeutics, Inc.
    Subjects: Anemia, Iron-Deficiency; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics
    Categories: Administration & Dosage; Drug Therapy; Adverse Effects; Analogs & Derivatives; Chemically Induced
    Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials. (2020)
    A prospective, multi-center, randomized comparison of iron isomaltoside 1000 versus iron sucrose in patients with iron deficiency anemia; the FERWON-IDA trial. (2019)

  20. Ponikowski, Piotr     ClinicalTrials.gov Google Publications
    Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Subjects: Anemia, Iron-Deficiency; Heart Failure; Ferric Compounds; Maltose; Iron; Iron Deficiencies
    Categories: Drug Therapy; Metabolism; Blood; Therapeutic Use; Physiopathology; Complications
    Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. (2020)
    Iron deficiency in chronic heart failure: an international pooled analysis. (2013)

Note:
  1. Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);